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ABSTRACT 
_____________________________________________________________________________________ 
The aqua-complexes (SM,RC)-[Cp*M{(R)-prophos}(H2O)][SbF6]2 (M = Rh (1), Ir (2)) catalyse the 
alkylation of , -unsaturated aldehydes with aromatics and heteroaromatics but in some cases, mixtures 
of products are obtained. Complexes 1 and 2 also activate nitroalkenes for the Friedel-Crafts alkylation of 
a variety of aromatics and heteroaromatics, in particular, 1,3,5-trimethoxybenzene. For this substrate, 
quantitative yield in the monoalkylated adduct and enantioselctivities up to 73% e.e. were achieved. The 
intermediate catalyst/nitroalkene is isolated and characterized and the complex catalyst/adduct is 
spectroscopically detected. From these data a plausible catalytic cycle is proposed. 
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1. Introduction 
The catalytic enantioselective Friedel-Crafts (FC) reaction of electron-rich aromatic 
or heteroaromatic substrates with electron-deficient alkenes is one of the most direct 
methods for introducing a new stereogenic centre on an aromatic or heteroaromatic 
compound.
1-9
 Asymmetric protocols based on both metal-
1-6
 and organocatalised 
1-4,6-9
 
alkylations have been developed. 
In particular, the asymmetric alkylation of activated alkenes, carbonyl compounds or 
imines was shown to take place for a number of (hetero)aromatic compounds and, 
although the first report on asymmetric FC reactions involved the alkylation of 
phenols
10
 and naphthols,
11
 indoles are by far the most widely employed 
nucleophiles.
3,4,6,7,9
 
We have recently isolated and characterized the chiral half-sandwich rhodium or 
iridium compounds (SM,RC)-[Cp*M{(R)-prophos}(H2O)][SbF6]2 (Cp* = C5Me5; M = 
Rh, Ir; prophos = propane-1,2-diylbis(diphenylphosphane)).
12,13
 These complexes easily 
lose water and the resulting unsaturated Lewis-acid cations (Figure 1) efficiently 
activate organic substrates, such as enals or , -unsaturated nitriles, for Diels-Alder
14-16
 
or 1,3-dipolar cycloadditions.
12,13,17-19
 Quantitative yields and excellent 
enantioselectivities have been achieved for both types of processes. 
 
 
 
Taking into account these results, we envisaged the possibility of applying this 
metallic fragment as catalyst for the FC alkylation of aromatic and heteroaromatic 
substrates with activated alkenes. We report here the results obtained. 
  
M*
Ph2P
PPh2
2+
*
Figure 1.  The chiral cations Cp*M{(R)-prophos)}
M = Rh, Ir
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2. Results and discussion 
2.1 Enals as electrophiles 
We first examined the homogeneous asymmetric FC alkylation of a series of 
activated arenes, pyrroles and indoles (Scheme 1) with enals in the presence of 5 mol % 
of the catalyst precursors (SM,RC)-[Cp*M{(R)-prophos}(H2O)][SbF6]2 (M = Rh (1), Ir 
(2)). Although 2,3-dimethylacrolein (7c) and trans-cinnamaldehyde (7d) were tested as 
enals, most of the reactions were carried out with methacrolein (7a) or trans-
crotonaldehyde (7b) (Scheme 2). Dichloromethane was used as solvent and reactions  
 
 
 
 
 
were carried out at -10ºC, in the presence of 4Å molecular sieves (MS). A 1/20/60: 
catalyst/aromatic/enal molar ratio was employed. According to NMR data, after 72 
hours of treatment in these conditions, no reaction was observed between 
monosubstituted arenes 3a-c and trans-crotonaldehyde nor between 3b,c and 
methacrolein. Under the same conditions, more activated arenes such as 1,3-dimethoxy- 
or 1,3,5-trimethoxy-benzene do not react either. However, the iridium complex 2 
catalyses the reaction between m-N,N-dimethyl anisidine (4a) and trans-crotonaldehyde 
(7b). After 72 hours of reaction, the monosubstituted FC product at the para position 
with respect to the amine was obtained in 49% isolated yield and in 26% e.e., measured 
on the alcohol obtained by reduction with NaBH4 (Scheme 3). Analogously, complex 2 
catalyses the reaction between the anisidine 4a and methacrolein, but a mixture of three 
compounds was obtained. After reduction with NaBH4, the major product was 
characterized as the alcohol 8c. NMR data indicate that the two remaining products are  
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the other two possible monosubstituted FC adducts 8d and 8e. Quantitative conversion 
was achieved after 72 hours of reaction with the product distribution and 
enantioselectivity, measured on the alcohol derivatives, depicted in Scheme 4. 
 
 
 
No reaction was observed between 4a and the enals 2,3-dimethylacrolein (7c) and 
trans-cinnamaldehyde (7d). Surprisingly, under the above mentioned conditions, the 
rhodium complex (SM,RC)-[Cp*Rh{(R)-prophos}(H2O)][SbF6]2 (1) does not catalyse the 
reaction between anisidine 4a and the enals 7a and 7b. 
Thus, poor results are obtained, but, to our knowledge, this is the first example of 
alkylation of activated arenes with enals using metal-based catalysts. In this context, an 
organocatalysed reaction of anilines and metoxianilines with , -unsaturated aldehydes 
was recently reported by MacMillan and Paras.
20
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Next, we examined the FC reaction of pyrroles and indoles with enals. At -10ºC, N-
methyl pyrrol 5a reacts with trans-crotonaldehyde 7b giving the corresponding 2-
substituted FC adduct 8f, with 8% or 12% e.e. when the rhodium complex 1 or the 
iridium complex 2 were used as catalyst precursor, respectively (Scheme 5). No reaction 
was observed between N-benzyl pyrrol 5b and the enals 7a,b in the presence of 
complexes 1 or 2. 
Then, the reaction of a series of indoles with methacrolein and trans-crotonaldehyde 
was examined, using the iridium complex 2 as catalyst precursor
†
 (Scheme 6). The  
 
 
 
indole was alkylated at the 3-position in all the attempted cases. After 24-48 hours of 
reaction at -10ºC, isolated yield, in the alcohol obtained by subsequent reduction of the 
FC product, ranged from 15 to 58%. Enantiomeric excesses from 7 to 33% e.e. were 
achieved. The low yield was accompanied by the formation of several byproducts we 
were unable to completely characterize. However, when trans-crotonaldehyde 7b was 
used as electrophile, together with the expected alkylated indole (8h, 8j, 8l), we 
detected in the 
1
H NMR spectra of the crude of the reaction an ABX spin system 
consistent with the presence of a –C(Me)H–C(H)=C(H) connectivity in one of the 
byproduct in all the three cases. Figure 2 shows the 
1
H NMR peaks encountered in the 
crude of compound 8h and Table 1 collects the chemical shifts and coupling constants 
detected in the three experiments. It is likely that the formation of this common 
fragment involves the reaction of both unsaturated enal groups, namely the C=C and 
C=O double bonds. This fact, along with the, in general, poor results obtained in the  
______________ 
† When, under similar conditions, the rhodium compound 1 was employed as catalyst precursor, instead of the 
iridium compound 2, for the reactions between N-methylindole 6d and methacrolein or trans-crotonaldehyde, the 
corresponding FC adducts 8k and 8l were obtained in similar yield and enantioselectivity: 8j, 22% yield, 23% e.e.; 8l, 
49% yield, 16% e.e. (yield and e.e. measured after reduction to alcohol) 
+
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Figure 2. Selected fragments of the 
1
H NMR spectrum of the crude of the reaction between 6a 
and 7b. 
 
Table 1 
Chemical shifts and coupling constants for the detected –C(Me)H–C(H)=C(H) moieties 
Indole HA HB HX Me 
 , ppm JXA, Hz , ppm JAB, Hz , ppm JMeX, Hz , ppm
6a 6.48 6.9 6.71 16.0 3.98 7.0 1.62 
6c 6.55 5.6 6.64 16.4 4.01 7.1 1.64 
6d 6.44 6.9 6.69 15.9 3.97 6.5 1.73 
 
alkylation reaction of enals, prompted us to try nitrostyrenes as electrophiles. We 
expected that the nitro group on the one side would provide the substrate with binding 
capability and on the other would activate the C=C double bond without interfering in 
its FC reactivity. 
 
2.2 trans- -Nitrostyrenes as electrophiles 
Examples of homogeneous catalytic enantioselective addition of aromatic and 
heteroaromatic C-H bonds to nitroolefins appeared only recently. In 2005, Bandini, 
Umani-Ronchi, et al. reported the enantioselective condensation of indole with 
nitroalkenes catalysed by [AlCl(salen)] (salen = (R,R)-(−)-N,N’-bis(3,5-di-t-
butylsalicylidene)-1,2-cyclohexanediamine).
21
 In the same year, Jørgensen and 
coworkers developed hydrogen-bond-based organocatalysts for this reaction.
22
 Since 
then, a handful of metal-catalysed
23-37
 and a few organocatalysed
38-45
 examples have 
been reported. Copper
25,26,31,33,37
 and zinc
23,24,27-30,32,34-36
 are the only metals employed 
with nitrogen and/or oxygen donor ligands as chiral source. The organocatalysts tried 
7 
 
are based on thioureas,
38-40,45
 phosphoric acids
42-44
 or quinolinium amido(thio)amides.
41
 
Indoles alkylation with nitroolefins is by far the most investigated reaction.
21-26,28,29,31-
39,41,42
 Pyrroles,
28,30,33,43
 4,7-dihydroindoles,
44
 phenol
45
 and naphthols
40,45
 are much less 
studied, and one example of the addition of nitroolefins to 2-methoxyfuran
27
 has been 
recently published. 
Taking into account all precedent, we decide to investigate the FC alkylation of 
nitroolefins, specifically trans- -nitrostyrenes, by introducing catalysts based on two 
new metals, rhodium and iridium, with a chiral diphosphane ligand namely, (R)-
prophos, as chiral source. 
 
 
 
First, we examined the reaction of trans- -nitrostyrene, as alkene model, with a 
series of activated arenes (3c, 4a-c), N-methyl pyrrol (5a) and indole (6a) using the 
iridium complex 2 as catalyst precursor (Scheme 7). Dichloromethane was used as 
solvent and reactions were carried out at -10ºC, in the presence of 4Å MS. A 1/20/20: 
catalyst/aromatic/trans- -nitrostyrene molar ratio was employed. According to 
spectroscopic and chromatographic data, quantitative yield was obtained in all cases, 
but for phenyltrimethylsilane 3c and 1,3-dimethoxybenzene 4b. No reaction was 
observed for the monosubstituted arene 3c after 72 hours of treatment and a yield of 
17%, with 2% of e.e., was measured, after the same time of reaction, for 4b. Reactions 
were completely regioselective. Only monosubstituted FC adducts were detected: the 
R3
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N
Me
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N
H
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Scheme 7. Reaction of several aromatics and heteroaromatics with trans- -nitrostyrene
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arene substituted at the para position with respect to the amine (10a), for m-N,N-
dimethyl anisidine (4a) and the 2-substituted pyrrol 10d or 3-substituted indole 10e for 
the heteroaromatic substrates
‡
. Enantiomeric excesses ranging from 3 to 40% e.e. were 
achieved. 
Table 2 
Reactions between 1,3,5-trimethoxybenzene and trans- -nitrostyrenes 
 
Entry R t (h) Yield (%) E.e. (%) Adduct 
1 H (9c) 6 >99 40 10c 
2 4-Me (9f) 14 >99 54 10f 
3 2-OMe (9g) 16 94 73 10g 
4 3-OMe (9h) 7 >99 18 10h 
5 4-OMe (9i) 15 >99 51 10i 
6 2-OBn (9j) 17 69 69 10j 
7 3-OBn (9k) 21 83 15 10k 
8 4-OBn (9l) 17 98 43 10l 
9 2,3-(OMe)2 (9m) 24 89 70 10m
a
 
10 2,4-(OMe)2 (9n) 22 22 51 10n 
11 2,5-(OMe)2 (9o) 24 95 40 10o 
12 3,4-(OMe)2 (9p) 22 92 67 10p 
13 3,4-(OBn)2 (9q) 25 96 20 10q 
14 3,5-(OBn)2 (9r) 18 >99 9 10r 
15 3-OBn,4-OMe (9s) 18 97 35 10s 
16 2-F (9t) 4 >99 22 10t 
17 2-Cl (9u) 22 92 31 10u 
18 2-Br (9v) 25 89 21 10v 
19 4-Cl (9w) 22 >99 9 10w 
20 4-Br (9x) 16 >99 9 10x 
21 2,3-(Cl)2 (9y) 40 95 0 10y 
22 2,4-(Cl)2 (9z 17 60 0 10z 
23 2,6-(Cl)2 (9ab) 49 2.5 3 10ab 
24 2-Cl,6-F (9ac) 118 50 47 10ac 
25 2-CF3 (9ad) 96 22 9 10ad 
a 
Enantiopure samples (> 99.9% e.e.) of 10m can be obtained by crystallization from CH2Cl2/n-
hexane 
_________________ 
‡ The low yield does not allow the complete NMR characterization of adduct 10b. 
OMe
OMeMeO
NO2
+
R
OMe
OMeMeO
NO2
H
*
R
Cat.*  5 mol %
CH2Cl2, 4Å MS
4c 109
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As the best result was obtained for 1,3,5-trimethoxybenzene (4c) (quantitative yield 
after 6 hours of reaction, 40% e.e.) and this substrate has not been investigated 
previously in this type of FC reaction, we next studied the reactivity between 4c and a 
family of trans- -nitrostyrenes. Table 2 lists the results obtained when the catalytic 
reactions were carried out with complex 2 as catalyst precursor, under the conditions 
above reported for unsubstituted trans- -nitrostyrene. The collected results are the 
average of at least two comparable reaction runs. Reactions are clean: only the 
monoalkylated adduct was spectroscopically and chromatographically detected.
§
 
Catalyst precursors have to be treated with the corresponding nitroolefin in the presence 
of 4Å MS before the addition of the arene. In these conditions, [Cp*M{(R)-
prophos}(nitroolefin)]
2+
 were the sole metallic complexes present in solution (see 
below). 
In general, high yield are obtained after a few hours of reaction at -10ºC. E.e.’s up to 
73% were achieved. Both, electron donating and electron withdrawing groups generate 
less active systems (compare, for example, entry 1 with entries 3 and 6 or with entries 
17 and 18). Only the 3-methoxy and the 2-fluoro substituted substrates (entries 4 and 
16, respectively) present a catalytic rate comparable to that of the unsubstituted 
nitroolefin. In this line, the lowest rates correspond to nitroolefins with two substituents 
on the aromatic ring. Probably, this trend is originated by the increase in the steric 
hindrance of the alkylation reagent. 
 
 
 
Electronic factors strongly affect the enantioselectivity of the system. Thus, while 
electron donating substituents located at 2 or 4 positions of the aromatic ring improve 
______________ 
§ The low yield does not allow the complete NMR characterization of adducts 10ab and 10ad. 
 
Figure 3. Plot of the e.e. obtained in the reaction of the nitroolefins 9c, 9f, 9h, 9i, 9w, and 9x, versus the 
Hammet parameter  
10 
 
e.e. (compare entry 1 with entries 3 and 5 or 6 and 8), it diminishes when substituents of 
this type are placed at position 3 (compare entry 1 with entries 4 or 7). However, two 
donor substituents situated at positions 2 and 4 do not produce further improvement on 
the e.e. (compare entries 3 and 5 with entry 10). Conversely, lower e.e.’s are obtained 
with electron withdrawing substituents. The 2,6-disubstituted nitroolefin 9ac, that gives 
a 47 % e.e. (entry 24), is the only exception to this trend. In this context, Bandini, 
Umani-Ronchi, et al. found a good degree of correlation between the enantiomeric 
excess of the products and the Hammet parameter
46
 associated to the nitroalkene 
substituent, for the FC reaction between indoles and nitroalkenes, catalysed by 
aluminium-salen complexes.
21
 Reflecting the influence of the electronic factors on the 
e.e. outcome, we have found a similar trend by plotting the e.e.’s obtained versus the 
reported Hammet parameter  values for a series of nitroalkenes (Figure 3). 
 
2.3 Isolation and characterization of the catalyst/electrophile intermediate 
In spite of the fact that several metal-based catalytic systems have been applied to the 
FC reaction between aromatic or heteroaromatic substrates and nitroalkenes,
21,23-37
 as 
far as we know, no experimental data about the metallic intermediates involved in the 
catalytic reaction have been reported up to date. In some cases, the stereochemical 
outcome of the catalytic reactions has been explained by assuming that activation of the 
nitroalkene occurs through its monodentate
35,37
 or bidentate
23,24,28,31
 coordination to 
copper
31,37
 or zinc
23,24,28,35
 accompanied
24,28,35,37
 or not
23,28,31
 by additional interactions 
between the catalyst and the nucleophilic partner. 
To get an insight into the catalytic mechanism we studied the reaction between the 
catalyst precursors (SM,RC)-[Cp*M{(R)-prophos}(H2O)][SbF6]2 (M = Rh (1), Ir (2)) and 
the nitroalkene 9m, as a model. When 3 equivalents of 9m were added to 
dichloromethane solutions of complexes 1 or 2, in the presence of 4 Å MS, the complex 
cations [Cp*M{(R)-prophos}(9m)]
2+
 are instantaneously and quantitatively formed. 
From the solution solids of formula [Cp*M{(R)-prophos}(9m)][SbF6]2 (M = Rh (11), Ir 
(12)) can be isolated in around 80% yield (Equation 1). 
 
 
NO2
CH2Cl2, 4Å MS
9m
(SM,RC)-[Cp*M{(R)-profos}(H2O)][SbF6]2
M = Rh (1), Ir (2)
+
OMe
OMe
[Cp*M{(R)-profos}(9m)][SbF6]2
M = Rh (11), Ir (12)
(Eq. 1)
-H2O
11 
 
Complexes 11 and 12 were characterized by microanalysis and by IR, 
1
H, 
13
C, and 
31
P NMR spectroscopies (see Experimental). The reaction is completely 
diastereoselective; from -50ºC to RT only one set of sharp signals in observed in the 
NMR spectra of the three nuclei investigated. Assignment of the NMR peaks has been 
fulfilled by a combination of mono- and bi-dimensional, homo- and hetero-nuclear 
experiments. The 
1
H NMR spectrum reveals the presence of the Cp*, (R)-prophos and 
9m ligands in a 1/1/1 molar ratio. This technique unambiguously establishes the 
presence of coordinated 9m. Thus, for example for complex 11, two doublets centered 
at 7.31 (Hb, see Fig. 4) and 7.47 (Ha) ppm, with a coupling constant of 13.9 Hz, are 
attributed to the olefinic protons of the nitroalkene and the two methoxy substituents of 
the aromatic ring resonate as singlets at 3.87 (OMea) and 3.89 (OMeb) ppm. 
 
 
 
The 
31
P NMR spectrum of the rhodium complex 11 consists of two double doublets 
centered at 75.99 (J(Rh,P
1
) = 130.8 Hz, J(P
2
,P
1
) = 38.3 Hz) and at 51.52 ppm (J(Rh,P
2
) 
= 133.1 Hz) and that of the iridium compound 12 comprises two doublets centered at 
49.04 (P
1
) and 27.71 (P
2
) ppm with a coupling of 10.7 Hz. 
Important stereochemical conclusions can be drawn from the NMR experiments (Fig. 
4). Notably, the strong NOE relationship between the protons H21 and H11 and the 
methyl protons of one of the methoxy groups (OMea) support the S configuration at 
metal for both complexes. Thus, the reaction depicted in Eq. 1 takes place with retention 
of the configuration at metal. Furthermore, from the assignment of the resonances for 
the ortho protons of the phenyl rings of the (R)-prophos ligand, a  conformation can be 
inferred for the M-P
1
-C-C-P
2
 five-membered metallacycle. 
Hb
Ha OMea
OMebN
O
O
M
P1
P2
Me H21
Ph2
Ph1
Ph3
Ph4
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4
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H22
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*
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M
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O
N
HbHa
MeaO
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O
Figure 4. A: Cation of the complexes 11 (M = Rh) and 12 (M = Ir) showing the NMR labeling scheme.
B: NOE pattern measured for these cations
A B
*
*
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2.4 The catalyst/electrophile/1,3,5-trimethoxybenzene system 
After formation of the diastereopure electrophile containing species (SM,RC)-
[Cp*M{(R)-prophos}(9m)][SbF6]2 (M = Rh (11), Ir (12)), the next step of the catalytic 
process most likely should involve their interaction with the nucleophilic species 1,3,5-
trimethoxybenzene (4c). For this reason, we monitored by NMR the system generated 
by the addition of 4c to the rhodium complex 11. Figure 5 shows the evolution of the 
region of the 
31
P NMR spectra where the double doublets corresponding to the P
2
 
nucleus appear (see Figure 4). Each double doublet in this zone is related to one 
Rh{(R)-prophos} containing complex. Trace A corresponds to complex 11, formed in 
situ by addition of 2 equivalents of nitroalkene 9m to a CD2Cl2 solution of the aqua 
complex (SRh,RC)-[Cp*Rh{(R)-prophos}(H2O)][SbF6]2, in the presence of 4 Å MS, 
according to Equation 1. At -50ºC, two double doublets (labelled as complexes I and II, 
trace B) emerge when one equivalent of the arene 4c is added. These doublets correlate 
with two Cp* proton peaks at 1.30, (I) and 1.32 (II) ppm. At this temperature, the 
concentration of I and II increases with time at the expense of complex 11 (trace C) and 
the formation of FC adduct was not detected by 
1
H NMR spectroscopy. Heating up to  
-25ºC produces the decreasing of the concentration of II and the slowly formation of FC 
adduct (trace D). Finally, at -10ºC, the FC alkylation is quickly completed remaining 
very low concentrations of I and II (trace E).  
 
 
 
 
Figure 5. Fragment of the 
31
P NMR spectra for the reaction between the rhodium complex 11 
and 1,3,5,-trimethoxybenzene (see text) 
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To obtain more information about the nature of the species I and II, in an 
independent experiment, we added 1 equivalent of enantiopure FC adduct 10m (see 
footnote, in Table 2) to a CD2Cl2 solution of the aqua complex (SRh,RC)-[Cp*Rh{(R)-
prophos}(H2O)][SbF6]2, in the presence of 4 Å MS (Equation 2). At -50ºC, a new 
compound was formed that was characterized as II by comparison of its 
1
H and 
31
P 
NMR spectra with those recorded in the preceding experiment. 
 
 
 
Similarly, it was also monitored the reaction between the aqua complex 1 and a 
sample of 10m of 70% e.e. As expected, two new complexes appeared. The major one 
was complex II and the minor, complex III, presented a P
2
 double doublet centered at 
51.11 ppm that in the spectra of Figure 5 could be overlapped by the corresponding 
signal of complex 11. Thus, complex III has to be the isomer of complex II in which 
the less abundant enantiomer of the FC adduct 10m is coordinated to the [Cp*Rh{(R)-
prophos} moiety and the structure of the intermediate I remains unclear. We do not 
have data enough to propose a structure for it. However, from the evolution of the 
spectra shown in Figure 5, it seems that complex I is an intermediate formed by the 
interaction between 11 and the nucleophile 1,3,5-trimethoxybenzene (4c) before the 
catalyst/adduct complexes II and III are formed. 
 
 
OMe
OMeMeO
NO2
H
*
10m
OMe
OMe
CD2Cl2, 4Å MS(SM,RC)-[Cp*Rh{(R)-profos}(H2O)]
2+
1
+ [Cp*Rh{(R)-profos}(10m)]
2+ (Eq. 2)
-H2O
II
[M] nitroalkene 1,3,5-trimethoxybenzene
nitroalkene
[M] OH2
[M] adduct
nitroalkene
adduct
[M] = Cp*M{(R)-Prophos}
M = Rh, Ir
Figure 6. Proposed catalytic cycle
4 Å MS
complex 
type I
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2.5 Proposed catalytic cycle 
Taking together all the above observations we propose de catalytic cycle depicted in 
Figure 6. Nitroalkenes displace the coordinated molecule of water from the catalysts 
precursors (SM,RC)-[Cp*M{(R)-prophos}(H2O)][SbF6]2 (M = Rh (1), Ir (2)), in the 
presence of 4 Å MS, affording the corresponding nitroalkene complex, that is the true 
catalyst. These complexes react with free 1,3,5-trimethoxybenzene rendering catalyst-
adduct complexes probably via intermediates of the type I, that we have not been able to 
characterize. Adduct is dissociated by a new molecule of nitroalkene with concomitant 
regeneration of the metal-nitroalkene complex that re-stars a new catalytic cycle. 
 
3. Conclusions 
The chiral fragments Cp*M{(R)-prophos} (M = Rh, Ir) efficiently activate , -
unsaturated aldehydes and nitroalkenes for the Friedel-Crafts alkylation of a variety of 
aromatics and heteroaromatics. Clean reactions to the monoalkylated FC product are 
observed in most of the investigated cases. In particular, quantitative y regioselective 
conversion to the monoalkylated adduct was obtained in the reaction between 1,3,5-
trimethoxybenzene and nitroalkenes. The intermediates (SM,RC)-[Cp*M{(R)-
prophos}(9m)][SbF6]2 (M = Rh (11), Ir (12)) have been isolated and characterized. The 
catalyst/adduct complexes formed by the reaction of complex 11 with 1,3,5-
trimethoxybenzene have been spectroscopically detected. A catalytic cycle that includes 
these two types of intermediates is proposed. 
 
4. Experimental 
General: All solvents were treated in a PS-400-6 Innovative Technologies Solvent 
Purification System (SPS) and degassed prior to use. All preparations have been carried 
out under argon. Infrared spectra were obtained as KBr pellets with a Perkin-Elmer 
1330 spectrophotometer. Carbon, hydrogen and nitrogen analyses were performed using 
a Perkin-Elmer 2400 CHNS/O microanalyser. NMR spectra were recorded on Brucker 
Avance-300, 400 or 500 MHz spectrometers; unless otherwise stated all NMR 
measurements were carried at RT. 
1
H (300.13, 400.16, 500.13 MHz), 
31
P{
1
H} (161.96 
MHz) and 
13
C{
1
H} (75.48, 100.61, 125.77 MHz) NMR chemical shifts are reported in 
ppm relative to tetramethylsilane and referenced to partially deuterated solvent 
15 
 
resonances for 
1
H and 
13
C and H3PO4 (85%) for 
31
P. Coupling constants (J) are given in 
Hertz. NOEDIFF and 
1
H correlation spectra were obtained using standard procedures. 
Analytical high performance liquid chromatography (HPLC) was performed on an 
Alliance Waters (Waters 2996 PDA detector) instrument using the chiral columns 
Chiralcel OD–H (0.46 × 25 cm) and OD–H guard (0.46 × 5 cm) or Chiralpak AD–H 
(0.46 × 25 cm) or AS-H (0.46 × 25 cm). 
The complexes (SM,RC)–[Cp*M{(R)–Prophos}(H2O)](SbF6)2 (M = Rh (1), Ir (2)) 
were prepared using literature procedures
13
 with the following slightly modifications: 
To a suspension of [(Cp*MCl)2( -Cl)2] (0.400 mmol) in acetone (20 mL) 549.9 mg (1.6 
mmol) of AgSbF6 were added. The resulting suspension was stirred for 15 h and the 
precipitate was filtered off and washed with acetone (3 × 1 mL). The filtrate was 
vacuum-concentrated until ca. 5 mL and cooled down to -25ºC (Rh) or -50ºC (Ir). 
Under argon, at the corresponding temperature, 330.4 mg (0.800 mmol) of (R)-prophos 
were added and the solution stirred for 30 min. Addition of n-hexane (20 mL) and 
subsequent stirring gives orange (Rh) or yellow (Ir) solids. The solution was poured off 
and the solid washed with n-hexane (3 × 20 mL) and then vacuum-dried. The solids 
were recrystallized three times at -25ºC (Rh) or -50ºC (Ir) from CH2Cl2/n-hexane, 1/5, 
v/v. Yield: 92.3% (Rh), 88.7% (Ir). 
 
4.1.  General procedure for the reaction between aromatics or heteroaromatics 
and enals 
At -10ºC, in a thermostatic bath, a Schlenk flask equipped with a magnetic stirrer 
was introduced. Under argon, 0.03 mmol of (SM,RC)–[Cp*M{(R)–Prophos}(H2O)](SbF6)2, 
CH2Cl2 (4 mL), the corresponding enal (0.60 mmol) and about 100 mg of 4Å MS were 
added. The mixture was stirred for 15 minutes and then the corresponding aromatic or 
heteroaromatic reagent (1.80 mmol) was added. The reaction was monitored by tlc. 
After the appropriate reaction time, the suspension was vacuum-concentrated until 
dryness. The residue was extracted with Et2O (3 × 5 mL) and the solution vacuum-
evaporated until dryness. In some cases, the resulting oils were analysed and 
characterized by NMR and HPLC techniques. The residue was dissolved in ethanol 
(4mL) and 68.1 mg (1.80 mmol) of NaBH4 were added. After 15 min of reaction, 1 mL 
of a saturated solution of Na2CO3 in water was added. The mixture was extracted with 
CH2Cl2 (3 × 10 mL) and the organic phase was dried over MgSO4. The resulting 
16 
 
solution was vacuum-evaporated to dryness and purified by column chromatography 
(SiO2; AcEt/n-hexane, 40/60). Evaporation of the solvent gives pale oils that were 
analysed and characterized by NMR and HPLC techniques. 
4.1.1. 3-(4-(Dimethylamino)-2-methoxyphenyl)butanal (8a) 
This compound was characterized by comparison of its 
spectroscopic data with those reported in the literature.
20
 Yield: 
49%. E.e.: 26% (S). 
4.1.2. 3-(4-(Dimethylamino)-2-methoxyphenyl)-2-methylpropan-1-ol (8c) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 6.98 (pt, 1H, Hf), 6.34 
(bd, 1H, Hg), 6.33 (s, 1H, Hh), 3.86 (s, 3H, OMe), 3.40, 3.45 
(m, 2H, CH2OH), 2.96 (s, 6H, NMe2), 2.61, 2.50 (dd, J = 21.2, 
7.3 Hz, 2H, Hd + He), 1.92 (m, 1H, Hc), 0.97 (d, J = 7.3 Hz, 3H, Me). 
13
C RMN (75.48 
MHz, CDCl3) δ, ppm: 158.16 (C
9
), 150.51 (C
7
), 133.14 (C
5
), 117.09 (C
4
), 105.25, 96.61 
(C
6
, C
8
), 66.88 (C
1
), 55.39 (OMe), 40.99 (NMe2), 36.87 (C
2
), 28.84 (C
3
), 17.05 (Me). 
HPLC: Chiralpak AS-H (97/3, n-hexane/ethanol; 1.0 mL/min); tR, min: 10.9 (minor), 
12.7 (major). Yield: 67%. E.e.: 65%. 
4.1.3. 3-(2-(Dimethylamino)-4-methoxyphenyl-2-methylpropan-1-ol (8d) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 3.88 (s, 3H, OMe), 2.98 
(s, 6H, NMe2), 0.99 (bd, 3H, Me). 
13
C NMR (75.48 MHz, 
CDCl3) δ, ppm: 55.60 (OMe), 40.81 (NMe2), 20.43 ppm (Me). 
HPLC: Chiralpak AS-H (97/3, n-hexane/ethanol, 1.0 mL/min); tR, min: 15.25 (minor), 
16.31 (major). Yield: 22%. E.e.: 60%. 
4.1.4. 3-(2-(Dimethylamino)-5-methoxyphenyl-2-methylpropan-1-ol (8e) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 3.85 (s, 3H, OMe), 2.95 (s, 
6H, NMe2), 1.03 (d, J = 6.6 Hz, 3H, Me). 
13
C NMR (75.48 MHz, 
CDCl3) δ, ppm: 55.56 (OMe), 40.85 (NMe2), 19.66 (Me). HPLC: 
Chiralpak AS-H (97/3, n-hexane/ethanol, 1.0 mL/min); tR, min: 19.57 (minor), 20.63 
(major). Yield: 11%. E.e.: 73%. 
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4.1.5. 3-(1-Methyl-1H-pyrrol-2-yl)butanal (8f) 
This compound was characterized by comparison of its spectroscopic 
data with those reported in the literature.
47
 (Cat.* 1: Yield: 82%, E.e.: 
8% (S). Cat.* 2: Yield: 50%, E.e.: 12% (S). 
4.1.6. Characterization of the alcohol derived from 8g 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.96 (bs, 1H, NH), 7.55 (d, 
J = 7.8 Hz, 1H, Hf), 7.29 (d, J = 8.1 Hz, 1H, Hi), 7.12 (pt, 1H, Hh), 
7.04 (pt, 1H, Hg), 6.93 (d, J = 2.3 Hz, 1H, Hj), 3.52, 3.45 (dd, J = 
10.5, 5.9 Hz, 2H, Ha + Hb), 2.80, 2.56 (dd, J = 14.4, 6.6 Hz, 2H, Hd + 
He), 2.01 (oc, 1H, J = 6.8 Hz, Hc), 1.29 (bs, 1H, OH), 0.91 (d, J = 6.8 Hz, 3H, Me). 
13
C 
NMR (100.61 MHz, CDCl3) δ, ppm: 137.00 (C
10
), 128.23, 113.50 (C
4
, C
5
), 126.98 
(C
11
), 121.44 (C
7
), 119.13 (C
9
), 118.62 (C
8
), 111.09 (C
6
), 68.06 (C
1
), 36.87 (C
2
), 28.84 
(C
3
), 17.05 (Me). HPLC: Chiralpak AS-H (97/3, n-hexane/ethanol, 1.0 mL/min); tR, 
min: 53.8 (minor), 64.5 (major). Yield: 26%. E.e.: 22%. 
4.1.7. 3-(1H-Indole-3-yl)butanal (8h) 
This compound was characterized by comparison of its spectroscopic data 
with those reported in the literature.
48
 Yield: 15%. E.e.: 7%. 
4.1.8. Characterization of the alcohol derived from 8i 
1
H, NMR (300.13 MHz, CDCl3) δ, ppm: 8.00 (bs, 1H, NH), 7.15, 
6.92 (d, J = 8.6 Hz, 1H, Hf + Hg), 6.93 (s, 1H, Hh), 3.87 (s, 3H, 
OMe), 3.66, 3.55 (dd, J = 10.6, 5.4 Hz, 2H, Ha + Hb), 3.00, 2.70 
(dd, J = 14.7, 6.6 Hz, 2H, Hd + He), 2.61 (s, 3H, Me
12
), 2.05 (ps, 1H, J = 6.7 Hz, Hc), 
1.30 (bs, 1H, OH), 1.02 (d, J = 6.7 Hz, 3H, Me
13
). 
13
C NMR (75.48 MHz, CDCl3) δ, 
ppm: 151.40 (C
7
), 132.88, 126.93, 118.65, 115.39 (C
4
, C
5
, C
6
, C
10
) 124.10 (C
11
), 
110.18, 108.72 (C
8
, C
9
), 67.98 (C
1
), 58.26 (OMe), 37.44 (C
2
), 31.11 (C
3
), 16.96 (Me
13
), 
12.01 (Me
12
). HPLC: Chiralpak AS-H (97/3, n-hexane/ethanol, 1.0 mL/min); tR, min: 
50.8 (major), 61.4 (minor). Yield: 16%. E.e.: 26%. 
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4.1.9. Characterization of the alcohol derived from 8j 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.91 (bs, 1H, NH), 7.62 (d, 
J = 7.9 Hz, 1H, Hf), 7.30 (d, J = 7.9 Hz, 1H, Hi), 7.09 (pt, 1H, Hh), 
7.03 (pt, 1H, Hg), 3.53 (m, 2H, Ha + Hb), 3.17 (m, 2H, Hc + Hd), 
2.41 (s, 3H, C
11
Me), 2.06 (m, 1H, J = 6.8 Hz, Hc), 1.45 (d, J = 7.1 Hz, 3H, C
3
Me). 
13
C 
NMR (100.61 MHz, CDCl3) δ, ppm: 135.60, 130.63, 127.42, 115.22 (C
4
, C
5
, C
10
, C
11
), 
120.50 (C
8
), 119.11 (C
6
), 118.64 (C
7
), 110.28 (C
9
), 61.68 (C
1
), 39.52 (C
2
), 27.77 (C
3
), 
21.11 (Me). HPLC: Chiralpak AD-H (90/10, n-hexane/ethanol, 1.0 mL/min); tR, min: 
14.5 (minor), 19.2 (major). Yield: 16%. E.e.: 5%. 
4.1.10. Characterization of the alcohol derived from 8k 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.60 (d, J = 7.9 Hz, 1H, 
Hf), 7.28 (d, J = 8.2 Hz, 1H, Hi), 7.22 (pt, 1H, Hh), 7.12 (pt, 1H, 
Hg), 6.84 (s, 1H, Hj), 3.74 (s, 1H, NMe), 3.58, 3.50 (dd, J = 10.5, 
5.9 Hz, 2H, Ha + Hb), 2.84, 2.60 (dd, J = 14.4, 6.5 Hz, 2H, Hd + He), 2.05 (ps, 1H, J = 
6.8 Hz, Hc), 1.61 (bs, 1H, OH), 0.97 (d, J = 6.5 Hz, 3H, Me). 
13
C-RMN (75.48 MHz, 
CDCl3) δ, ppm: 137.00 (C
10
), 128.24, 113.05 (C
4
, C
5
), 126.98 (C
11
), 121.45 (C
7
), 119.15 
(C
9
), 118.64 (C
8
), 109.16 (C
6
), 68.06 (C
1
), 32.60 (NMe), 36.87 (C
2
), 28.84 (C
3
), 17.05 
(Me). HPLC: Chiralpak AS-H (95/5, n-hexane/ethanol, 1.0 mL/min); tR, min: 14.4 
(minor), 15.9 (major). Yield: 25%. E.e.: 28%. 
4.1.11. 3-(1-Methyl-1H-indole-3-yl)butanal (8l) 
This compound was characterized by comparison of its 
spectroscopic data with those reported in the literature.
48
 Yield: 58%. 
E.e.: 21% (S). 
4.1.12. Characterization of the alcohol derived from 8m 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.72 (s, 1H, Hf), 7.17 (bd, 
2H, Hg + Hh), 6.88 (s, 1H, Hi), 3.77 (s, 3H, NMe), 3.56 (m, 2H, Ha 
+ Hb), 2.83, 2.57 (dd, J = 14.3, 6.7 Hz, 2H, Hd + He), 2.04 (m, 1H, 
Hc), 1.27 (bs, 1H, OH), 0.99 (d, J = 6.7 Hz, 3H, Me). 
13
C NMR (75.48 MHz, CDCl3) δ, 
ppm: 135.67, 129.92, 112.82, 112.13 (C
4
, C
5
, C
7
, C
10
), 128.15 (C
11
), 124.22, 110.66 (C
8
, 
C
9
), 121.69 (C
6
), 67.88 (C
1
), 36.77 (C
2
), 32.83 (NMe), 28.62 (C
3
), 16.95 (Me). HPLC: 
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Chiralpak AS-H (97/3, n-hexane/ethanol, 1.0 mL/min); tR, min: 22.3 (major), 24.2 
(minor). Yield: 11%. E.e.: 19%. 
4.1.13. Characterization of the alcohol derived from 8n 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.42 (bd, 1H, Hf), 7.29 (bd, 
1H, Hi), 7.19 (pt, 1H, Hh), 7.08 (pt, 1H, Hg), 3.69 (s, 3H, NMe), 3.61, 
3.51 (m, 2H, Ha + Hb), 2.85, 2.59 (m, 2H Hd + He), 2.40 (s, 3H, 
Me
12
), 2.05 (m, 1H, J = 6.8 Hz, Hc), 0.91 (d, J = 6.8 Hz, 3H, Me
13
). 
13
C NMR (100.61 
MHz, CDCl3) δ, ppm: 136.56-107.15 (aromatic carbons), 68.20 (C
1
), 37.63 (C
2
), 29.56 
(NMe), 28.84 (C
3
), 17.10 (Me
13
), 10.46 (Me
12
). HPLC: Chiralpak AS-H (97/3, n-
hexane/ethanol, 1.0 mL/min); tR, min: 13.6 (minor), 16.1 (major). Yield: 33%. E.e.: 
33%. 
4.2.  General procedure for the reaction between aromatics or heteroaromatics 
and trans- -nitrostyrenes 
A Schlenk flask equipped with a magnetic stirrer was introduced in a thermostatic 
bath at -10ºC. Under argon, 0.03 mmol of (SM,RC)–[Cp*M{(R)–Prophos}(H2O)](SbF6)2, 
CH2Cl2 (4 mL), the corresponding trans- -nitrostyrene (0.60 mmol) and about 100 mg 
of 4Å MS were added. The resulting red mixture was stirred for 15 minutes and then the 
corresponding aromatic or heteroaromatic reagent (0.60 mmol) was added. The reaction 
was monitored by tlc. After the appropriate reaction time, the suspension was vacuum-
concentrated until dryness. The residue was extracted with Et2O (3 × 5 mL) and the 
solution vacuum-evaporated until dryness rendering a white or pale yellow solid that 
was analysed and characterized by NMR and HPLC techniques. 
4.2.1. 3-Methoxy-N,N-dimethyl-4-(2-nitro-1-phenilethyl)aniline (10a) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.45-7.36 (m, 5H, Ph), 6.78 (d, 
J = 9.4 Hz, He), 6.14-6.13 (m, 2H, Hd + Hf), 5.06 (dd, J = 8.3, 6.1 Hz, 
Hc), 4.82-4.93 (m, 2H, CH2), 3.73 (s, 3H, OMe), 2.84 ppm (s, 6H, 
NMe2). HPLC: Chiralcel AD-H (95/5, n-hexane/2-propanol, 0.5 
mL/min); tR, min: 27.3 (minor), 28.4 min (major). E.e.: 5%. 
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4.2.2. 2-(1-Phenyl-2-nitroethyl)-1,3,5-trimethoxybenzene (10c) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.33 (d, J = 7.8 Hz, 2H, Hb + 
Hc), 7.28 (pt, J = 6.8 Hz, 2H, Hd + He), 7.21 (pt, J = 6.8 Hz, 1H, Hf), 
6.15 (s, 2H, Hg + Hh), 5.52 (pt, J = 7.95 Hz, 1H, Ha), 5.26, 5.16 (dd, J = 
12.7, 7.9 Hz, 2H, C
1
H2), 3.82 (s, 9H, OMe). 
13
C NMR (100.61 MHz, 
CDCl3) δ, ppm: 160.52, (C
9
), 158.91 (C
7
, C
11
), 140.46 (C
6
), 128.78, 
128.74 (C
13
, C
17
), 128.67, 128.06 (C
16
, C
14
), 125.94 (C
15
), 108.58 (C
12
), 91,17 (C
8
, C
10
), 
78.10 (C
1
), 55.16-55.78 (C
3
, C
4
, C
5
), 38.55 (C
2
). HPLC: Chiralpak AD-H (90/10, n-
hexane/2-propanol, 0.5 mL/min); tR, min: 14.3 (minor), 15.0 (major). 
4.2.3. 2-(1-Phenyl-2-nitroethyl)-pyrrol (10d) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.07-7.21 (m, 5H, Ph), 6.43 
(s, 1H, Hpy), 6.01-6.06 (m, 2H, Hpy), 4.52-4.76 (m, 3H, CH2 + Ha), 
3.05 (s, 3H, NMe). HPLC: Chiralcel OD-H (80/20, n-hexane/2-
propanol, 1 mL/min); tR, min: 22.8 (minor), 29.5 (major). 
4.2.4. 3-(1-Phenyl-2-nitroethyl)-indole (10e) 
This compound was characterized by comparison of its 
spectroscopic data with those reported in the literature.
23
 E.e.: 3% 
(R). 
4.2.5. 2-(1-(4-Methylphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10f) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.11 (d, J = 8.0 Hz, 2H, Hd + 
Hg), 6.97 (d, J = 7.7 Hz, 2H, He + Hf), 6.04 (s, 2H, Hb + Hc), 5.37 (pt, J 
= 7.8 Hz, 1H, Ha), 5.13, 5.04 (dd, J = 12.9, 7.8 Hz, 2H, C
1
H2), 3.72 (s, 
6H, OMe
3
 + OMe
5
), 3.71 (s, 3H, OMe
4
), 2.21 (s, 3H, Me). 
13
C NMR 
(100.61 MHz, CDCl3) δ, ppm: 160.67, (C
9
), 158.97, (C
7
, C
11
), 137.62 
(C
6
), 136.46 (C
15
), 129.04 (C
13
, C
17
) 127.51 (C
14
, C
16
), 109.04 (C
12
), 91.17 (C
8
, C
10
), 
78.52 (C
1
), 55.80, 55.32 (C
3
, C
4
, C
5
), 38.32 (C
2
), 21.04 (Me). HPLC: Chiralpak AD-H 
(95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 16.5 (minor), 18.2 (major). 
4.2.6. 2-(1-(2-Methoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10g) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.24 (pt, 1H, Hf), 7.03 (d, J = 8.5 Hz, 1H, 
Hd), 6.87 (d, J = 8.5 Hz, 1H, Hg), 6.83 (pt, 1H, He), 6.19 (s, 2H, Hb + Hc), 5.80 (pt, J = 
6.1 Hz, 1H, Ha), 5.20, 5.07 (dd, J = 18.6, 6.1 Hz, 2H, C
1
H2), 3.89, 3.84, 3.79 (s, 12H, 
21 
 
OMe). 
13
C NMR (100.61 MHz, CDCl3) δ, ppm: 160.59 (C
9
), 159.17 
(C
7
, C
11
), 157.16, (C
17
), 129.14 (C
13
), 127.96 (C
15
), 127.48 (C
6
), 
120.33 (C
14
), 110.43 (C
16
), 107.39 (C
12
), 91,24 (C
8
, C
10
), 77.31 (C
1
), 
55.82, 55.44, 55.30 (C
3
, C
4
, C
5
, OMe
18
), 34.10 (C
2
). HPLC: 
Chiralpak AD-H (98/2, n-hexane/2-propanol, 0.25 mL/min); tR, min: 
78.0 (minor), 80.3 (major). 
4.2.7. 2-(1-(3-Methoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10h) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.19 (pt, 1H, He), 6.92 (d, J 
= 8.5 Hz, 1H, Hd), 6.90 (t, J = 1.9 Hz, 1H, Hg), 6.74 (dd, J = 8.5, 1.9 
Hz, 1H, Hf), 6.14 (s, 2H, Hb + Hc), 5.48 (pt, J = 7.7 Hz, 1H, Ha), 5.23, 
5.13 (dd, J = 20.3, 7.7 Hz, 2H, C
1
H2), 3.79 (s, 3H, OMe
4
); 3.82, 3.81, 
3.78 (s, 12H, OMe). 
13
C NMR (100.61 MHz, CDCl3) δ, ppm: 160.61, 
(C
9
), 159.51, (C
16
), 159.00 (C
7
, C
11
), 142.15 (C
6
), 129.21 (C
14
), 120.03 (C
13
), 113.97 
(C
17
), 111.54 (C
15
), 108.58 (C
12
), 91.24 (C
8
, C
10
), 78.35 (C
1
), 55.80, 55.30, 55.10 (C
3
, 
C
4
, C
5
, OMe
18
), 38.58 (C
2
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-propanol, 1 
mL/min); tR, min: 13.4 (minor), 14.7 (major). 
4.2.8. 2-(1-(4-Methoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10i) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.21 (d, J = 8.6 Hz, 2H, Hd + 
Hg), 6.76 (d, J = 8.6 Hz, 2H, He + Hf), 6.10 (s, 2H, Hb + Hc), 5.39 (pt, J 
= 7.7 Hz, 1H, Ha), 5.16, 5.06 (dd, J = 20.1, 7.7 H, 2H, C
1
H2), 3.77 (s, 
6H, OMe
3
 + OMe
5
), 3.76, 3.73 (s, 6H, OMe
4
 + OMe
18
). 
13
C-RMN 
(75.48 MHz, CDCl3) δ, ppm: 160.55 (C
9
), 158.53 (C
7
, C
11
), 158.21, 
(C
15
), 132.60 (C
6
), 128.69 (C
14
, C
16
), 113.69 (C
13
, C
17
), 108.83 (C
12
), 91,15 (C
8
, C
10
), 
78.78 (C
1
), 55.80, 55.29, 55.18 (C
3
, C
4
, C
5
, OMe
18
), 38.02 (C
2
). HPLC: Chiralpak AD-
H (95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 28.8 (minor), 33.8 min (major). 
4.2.9. 2-(1-(2-Benzyloxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10j) 
1
H NMR (400.16 MHz, CD3COCD3) δ, ppm: 7.52-6.82 (m, 9H, Har), 
6.27 (s, 2H, Hb + Hc), 5.93 pt, J = 7.2 Hz, 1H, Ha), 5.22-5.05 (m, 4H, 
C
1
H2 + CH2Ph), 3.82 (s, 3H, OMe
4
), 3.74 (s, 6H, OMe
3
 + OMe
5
). 
13
C 
NMR (100.61 MHz, CD3COCD3) δ, ppm: 160.90, 159.75, 156.22 
22 
 
(C
7
, C
9
, C
11
, C
17
), 137.62 (C
6
), 129.14-112.11 (C
13
, C
14
, C
15
, C
16
, C
12
, and C, Ph), 91.35 
(C
8
, C
10
), 76.85 (C
1
), 69.77 (CH2Ph), 55.20, 54.70 (C
3
, C
4
, C
5
), 33.86 (C
2
). HPLC: 
Chiralpak AD-H (95/5, n-hexane/2-propanol, 0.25 mL/min); tR,min: 75.2 (minor), 77.3 
(major). 
4.2.10 2-(1-(3-Benzyloxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10k) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.50-6.81 (m, 9H, Har), 
6.14 (s, 2H, Hb + Hc), 5.47 (pt, J = 7.8 Hz, 1H, Ha), 5.23, 5.12 (dd, 
J = 12.8, 7.8 Hz, 2H, C
1
H2), 5.03 (s, 2H, CH2Ph), 3.81 (s, 3H, 
OMe
4
),3.79 (s, 6H, OMe
3
 + OMe
5
). 
13
C-RMN (100.61 MHz, 
CDCl3) δ, ppm: 161.94, 160.59, 158.98, 158.76 (C
7
, C
9 
, C
11
, C
16
), 
142.17 (C
6
), 137.04-108.47 (C
13
, C
14
, C
15
, C
17
, C
12
, and C, Ph), 92.90 (C
8
, C
10
), 76.85 
(C
1
), 69.77 (CH2Ph), 55.20, 54.70 (C
3
, C
4
, C
5
), 33.86 (C
2
). HPLC: Chiralpak AD-H 
(95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 34.6 (minor), 38.4 (major). 
4.2.11. 2-(1-(4-Benzyloxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10l) 
1
H NMR (500.13 MHz, CDCl3) δ, ppm: 7.44-7.32 (m, 5H, Har), 7.27 (d, 
J = 13.7 Hz, 2H, Hd + Hg), 6.77 (d, J = 13.7 Hz, 2H, He + Hf), 6.04 (s, 
2H, Hb + Hc), 5.46 (pt, J = 7.8 Hz, 1H, Ha), 5.22, 5.12 (dd, J = 19.76, 
7.40, 2H, C
1
H2), 5.04 (CH2Ph), 3.83 (s, 6H, OMe
3
 + OMe
5
), 3.82 (s, 
3H, OMe
4
). 
13
C NMR (125.77 MHz, CDCl3) δ, ppm: 160.52, 158.93, 
157.54 (C
7
, C
9
, C
11
, C
15
), 137.13 (C
6
), 132.93, 128.76, 128.59, 127.95, 127.49, 114.65, 
108.93 (C
13
, C
14
, C
16
, C
17
, C
12
, and C, Ph), 91.22 (C
8
, C
10
), 78.68 (C
1
), 70.01 (CH2Ph), 
55.83, 55.33 (C
3
, C
4
, C
5
), 38.07 (C
2
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-
propanol, 0.5 mL/min); tR, min: 32.4 (minor), 36.5 (major). 
4.2.12. 2-(1-(2,3-Dimethoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10m) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 6.95, 6.81, 6.80 (3H, Har), 
6.14 (s, 2H, Hb + Hc), 5.78 (pt, J = 6.9 Hz, 1H, Ha), 5.01, 5.18 (dd, 
J = 19.5, 6.9, 2H, C
1
H2), 3.88, 3.86, 3.81, 3.79 (s, 15H, OMe). 
13
C 
NMR (100.61 MHz, CDCl3) δ, ppm:): 160.67, (C
9
), 159.52, 
152.68 (C
7
, C
11
), 147.1, 133.49 (C
16
, C
17
), 123.49 (C
6
), 120.86 
23 
 
(C
13
), 111.11 (C
14
), 125.94 (C
15
), 107.73 (C
12
), 91,26 (C
8
, C
10
), 77.34 (C
1
), 60.44-55.28 
(C
3
, C
4
, C
5
, C
18
, C
19
), 33.94 (C
2
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-propanol, 
0.5 mL/min); tR, min: 34.3 (minor), 35.9 (major). 
4.2.13. 2-(1-(2,4-Dimethoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10n) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 6.95-6.80 (m, 3H, Har), 6.14 (s, 
2H, Hb + Hc), 5.30 (pt, J = 7.0 Hz, 1H, Ha), 4.80, 4.64 (dd, J = 11.8, 7.0 
Hz, 2H, C
1
H2), 3.58 (s, 6H, OMe
3
 + OMe
5
), 3.57, 3.55, 3.52 ppm (s, 9H, 
OMe
4
 + OMe
18
 + OMe
19
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-
propanol, 0.5 mL/min); tR, min: 36.8 (minor), 38.4 (major). 
4.2.14. 2-(1-(2,5-Dimethoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10o) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 6.71 (d, J = 8.8 Hz, 1H, 
Hd), 6.63 (dd, J = 8.8, 3.0 Hz, 1H, He), 6.56 (d, J = 3.0 Hz, 1H, Hf), 
6.07 (s, 2H, Hb + Hc), 5.67 (pt, J = 8.6 Hz, 1H, Ha), 5.10, 4.94 (dd, J 
= 12.4, 8.5 Hz, 2H, C
1
H2), 3.77, 3.73, 3.59 (s, 9H, OMe
4
 + OMe
18
 + 
OMe
19
), 3.70 (s, 6H, OMe
3
 + OMe
5
). HPLC: Chiralpak AD-H 
(95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 31.2 (minor), 34.3 (mayor). 
4.2.15. 2-(1-(3,4-Dimethoxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10p) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 6.92 (d, J = 1.9 Hz, 1H, Hd), 
6.89 (dd, J = 8.3, 1.9 Hz, 1H, Hf), 6.77 (d, J = 8.3 Hz, 1H, He), 6.14 
(s, 2H, Hb+ Hc), 5.44 (pt, J = 7.8 Hz, 1H, Ha), 5.22, 5.11 (dd, J = 12.7, 
7.8 Hz, 2H, C
1
H2), 3.85 (s, 6H, OMe
3
 + OMe
5
), 3.84 (s, 6H, OMe
18
 + 
OMe
19
), 3.81 (s, 3H, OMe
4
). 
13
C NMR (100.61 MHz, CDCl3) δ, ppm: 
161.55, 160.53, 158.91, 148.68, 147.79 (C
7
, C
9
, C
11
, C
14
, C
15
), 133.10 (C
6
), 119.77 
(C
17
), 11.33 (C
13
), 111.01 (C
16
), 108.84 (C
12
), 91,26 (C
8
, C
10
), 78.77 (C
1
), 55.81-55.32 
(C
3
, C
4
, C
5
, C
18
, C
19
), 38.48 (C
2
). HPLC: Chiralpak AD-H (90/10, n-hexane/2-propanol, 
1 mL/min); tR, min = 35.5 (minor), 53.4 (major). 
4.2.16. 2-(1-(3,4-Dibenzyloxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10q) 
1
H NMR (500.13 MHz, CDCl3) δ, ppm: 7.44-7.28 (m, 10H, Ph
18
 + Ph
19
), 6.94 (bd, 
1H, Hd), 6.83 (m, 2H, He + Hf), 6.12 (s, 2H, Hb + Hc), 5.38 (pt, J = 7.8 Hz, 1H, Ha), 
5.16-4.98 (m, 6H, C
1
H2 + CH2Ph
18
 + CH2Ph
19
), 3.81 (s, 3H, OMe
4
), 3.75 (s, 6H, OMe
3
 
24 
 
+ OMe
5
). 
13
C NMR (125.77 MHz, CDCl3) δ, ppm: 160.52, 158.88, (C
7
, C
9 
, C
11
, C
14
, C
15
), 137.46 (C
6
), 148.58-108.78 (C
13
, C
16
, C
17
, C
12
, and C, Ph), 
91.25 (C
8
, C
10
), 78.60 (C
1
), 71.42, 71.31 (CH2Ph
18
, CH2Ph
19
), 55.77, 55.31 
(C
3
, C
4
, C
5
), 38.25 (C
2
). HPLC: Chiralpak AD-H (80/20, n-hexane/2-
propanol, 1 mL/min); tR, min: 20.5 (minor), 34.2 (major). 
4.2.17. 2-(1-(3,5-Dibenzyloxyphenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10r) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.32-7.21 (m, 10H, Ph
18
 
+ Ph
19
), 6.48 (d, J = 2.0 Hz, 2H, Hd + Hf), 6.37 (t, J = 2.0 Hz, 1H, 
He), 6.02 (s, 2H, Hb + Hc), 5.32 (pt, J = 7.8 Hz, 1H, Ha), 5.08-4.99 
(dd, J = 12.9, 7.8, 2H, C
1
H2), 4.89 (bs, 4H, CH2Ph), 3.70 (s, 3H, 
OMe
4
), 3.66 (s, 6H, OMe
3
 + OMe
5
). 
13
C-RMN (125.77 MHz, 
CDCl3) δ, ppm: 160.62, 159.80, 159.00 (C
7
, C
9 
,C
11
, C
14
, C
16
), 142.95-108.38 (C
6
, C
12
, 
C, Ph), 107.19 (C
13
, C
17
), 100.15 (C
15
), 91.24 (C
8
, C
10
), 78.31 (C
1
), 70.06 (CH2Ph
18
, 
CH2Ph
19
), 55.82, 55.33 (C
3
, C
4
, C
5
), 38.72 (C
2
). HPLC: Chiralpak AD-H (80/20, n-
hexane/2-propanol, 1 mL/min); tR, min: 11.2 (minor), 13.4 (major). 
4.2.18 2-(1-(3-Benzyloxy-4-methoxyphenyl)-2-nitroethyl)-1,3,5-
trimethoxybenzene (10s) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.32-7.18 (m, 5H, Ph
18
), 6.80 
(m, 2H, He + Hf), 6.70 (bd, 1H, Hd), 6.02 (s, 2H, Hb + Hc), 5.27 (pt, J 
= 7.8 Hz, 1H, Ha), 5.05-4.92 (m, 4H, C
1
H2 + CH2Ph), 3.76, 3.71 (s, 
6H, OMe
4
 + OMe
19
), 3.64 (s, 6H, OMe
3
 + OMe
5
). 
13
C-RMN (75.48 
MHz, CDCl3) δ, ppm: 160.50, 158.86 (C
7
, C
9 
, C
11
, C
14
, C
15
), 148.48-
108.86 (C
6
, C
12
, C
13
, C
16
, C
17
, and C, Ph), 91.27 (C
8
, C
10
), 78.64 (C
1
), 71.12 (CH2Ph
14
), 
56.00, 55.75, 55.30 (C
3
, C
4
, C
5
, C
19
), 38.26 (C
2
). HPLC: Chiralpak AD-H (90/10, n-
hexane/2-propanol, 1 mL/min); tR, min: 21.8 (minor), 36.1 (major). 
4.2.19. 2-(1-(2-Fluorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10t) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.28-6.93 (m, 4H, Har), 6.16 (s, 
2H, Hb + Hc), 5.78 (pt, J = 8.0 Hz, 1H, Ha), 5.16 (d, J = 7.8 Hz, 2H, 
C
1
H2), 3.82 (s, 3H, OMe
4
), 3.81 (s, 6H, OMe
3
 + OMe
5
). 
13
C-RMN 
(100.61 MHz, CDCl3) δ, ppm: 160.52, (C
9
), 158.97 (C
7
, C
11
), 137.47, 
 
25 
 
136.15 (C
17
, C
6
), 129.02, 127.50 (C
13
, C
14
, C
15
, C
16
), 108.80 (C
12
), 91,19 (C
8
, C
10
), 
78.52 (C
1
), 55.80, 55.30 (C
3
, C
4
, C
5
), 38.32 (C
2
). HPLC: Chiralpak AD-H (95/5, n-
hexane/2-propanol, 0.5 mL/min); tR, min: 18.9 (minor), 20.0 (major). 
4.2.20. 2-(1-(2-Chlorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10u) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.32, 7.14 (m, 4H, Har), 6.12 
(s, 2H, Hb + Hc), 5.80 (pt, J = 7.0 Hz, 1H, Ha), 5.19, 4.99 (dd, J = 20.1, 
7.0 Hz, 2H, C
1
H2), 3.79 (s, 3H, OMe
4
); 3.76 (s, 6H, OMe
3
 + OMe
5
). 
13
C NMR (100.61 MHz, CDCl3) δ, ppm: 160.84, (C
9
), 159.51 (C
7
, C
11
), 
137.25, 133.99 (C
17
, C
6
), 129.83, 129.72, 128.07, 126.62 (C
13
, C
14
, C
15
, 
C
16
), 106.70 (C
12
), 91,19 (C
8
, C
10
), 76.44 (C
1
), 55.77, 55.30 (C
3
, C
4
, C
5
), 36.85 (C
2
). 
HPLC: Chiralpak AD-H (95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 19.1 
(minor), 20.3 (major). 
4.2.21. 2-(1-(2-Bromophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10v) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.55 (d, J = 8.2 Hz, 1H, Hg), 
7.34 (d, J = 7.7 Hz, 1H, Hd), 7.21 (pt, J = 7.2 Hz, 1H, Hf), 7.08 (pt, J = 
7.7 Hz, 1H, He), 6.15 (s, 2H, Hb + Hc), 5.77 (pt, J = 8.2 Hz, 1H, Ha), 
5.25, 4.95 (dd, J = 12.8, 8.2, 2H, C
1
H2), 3.81 (s, 3H, OMe
4
), 3.79 (s, 
6H, OMe
3
 + OMe
5
). 
13
C NMR (75.48 MHz, CDCl3) δ, ppm: 160.85 
(C
9
), 159.56 (C
7
, C
11
), 139.01, 124.52 (C
17
, C
6
), 133.10, 130.10, 128.38, 127.36 (C
13
, 
C
14
, C
15
, C
16
), 106.97 (C
12
), 91.29 (C
8
, C
10
), 76.49 (C
1
), 55.77, 55.30 (C
3
, C
4
, C
5
), 39.61 
(C
2
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 18.6 
(minor), 19.2 (major). 
4.2.22. 2-(1-(4-Chlorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10w) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.29-7.22 (m, 4H, Har), 6.14 
(s, 2H, Hb + Hc), 5.47 (pt, J = 8.1 Hz, 1H, Ha), 5.26, 5.06 (dd, J = 12.8, 
8.1 Hz, 2H, C
1
H2), 3.82 (s, 6H, OMe
3
 + OMe
5
), 3.81 (s, 3H, OMe
4
). 
13
C NMR (100.61 MHz, CDCl3) δ, ppm: 160.77 (C
9
), 158.83 (C
7
, 
C
11
), 139.11 (C
15
), 132.33 (C
6
), 129.01, 128.42 (C
13
, C
14
, C
16
, C
17
), 
108.18 (C
12
), 91,13 (C
8
, C
10
), 78.08 (C
1
), 55.80, 55.35 (C
3
, C
4
, C
5
), 37.98 (C
2
). HPLC: 
Chiralpak AD-H (95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 34.6 (minor), 40.2 
min (major). 
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4.2.23. 2-(1-(4-Bromophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10x) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.37 (d, J = 8.4 Hz, 2H, He + 
Hf), 7.19 (d, J = 8.4 Hz, 2H, Hd + Hg), 6.12 (s, 2H, Hb + Hc), 5.45 (pt, 
J = 7.4 Hz, 1H, Ha), 5.24, 5.04 (dd, J = 19.8, 7.4 Hz, 2H, C
1
H2), 3.80 
(s, 9H, OMe). 
13
C NMR (75.48 MHz, CDCl3) δ, ppm: 160.83 (C
9
), 
158.86 (C
7
, C
11
), 139.69 (C
15
), 131.36 (C
14
, C
16
), 129.37 (C
13
, C
17
), 
120.43 (C
6
), 108.22 (C
12
), 91.24 (C
8
, C
10
), 78.00 (C
1
), 55.80, 55.33, (C
3
, C
4
, C
5
), 38.06 
(C
2
). HPLC: Chiralpak AD-H (90/10, n-hexane/2-propanol, 0.5 mL/min); tR, min: 14.6 
(minor), 16.6 (major). 
4.2.24. 2-(1-(2,3-Dichlorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10y) 
1
H NMR (300.13 MHz, CDCl3) δ, ppm: 7.60-6.64 (m, 3H, Har), 6.14 (s, 
2H, Hb + Hc), 5.78 (pt, J = 6.9 Hz, 1H, Ha), 5.22, 4.95 (dd, J = 12.7, 
6.9, 2H, C
1
H2), 3.75 (s, 3H,), 3.81, 3.69 (s, 9H, OMe
3
 + OMe
4
 + 
OMe
5
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-propanol, 0.5 
mL/min); tR, min: 26.7, 28.9. 
4.2.25 2-(1-(2,4-Dichlorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene (10z) 
1
H RMN (500.13 MHz, CDCl3) δ, ppm: 7.37 (d, J = 2.2 Hz, 1H, 
Hd), 7.30 (d, J = 8.6 Hz, 1H, Hf), 7.15 (dd, J = 8.6, 2.2 Hz, 1H, 
He), 6.14 (s, 2H, Hb + Hc), 5.77 (pt, J = 8.6 Hz, 1H, Ha), 5.14, 5.01 
(dd, J = 12.7, 8.6 Hz, 2H, C
1
H2), 3.82 (s, 3H, OMe
4
), 3.79 (s, 6H, 
OMe
3
 + OMe
5
). 
13
C NMR (125.77 MHz, CDCl3) δ, ppm: 161.01 
(C
9
), 159.37 (C
7
, C
11
), 136.02, 134.67 (C
13
, C
15
), 133.07 (C
6
), 
130.65 (C
17
), 129.43 (C
14
), 126.86 (C
16
), 106.17 (C
12
), 91.15 (C
8
, C
10
), 76.27 (C
1
), 
55.74, 55.32, (C
3
, C
4
, C
5
), 36.36 (C
2
). HPLC: Chiralpak AD-H (95/5, n-hexane/2-
propanol, 0.5 mL/min); tR, min: 24.3, 26.7. 
2.2.26 2-(1-(2-Chloro-6-fluorophenyl)-2-nitroethyl)-1,3,5-trimethoxybenzene 
(10ac) 
1
H NMR (400.16 MHz, CDCl3) δ, ppm: 7.41-6.48 (m, 3H, Har), 6.05 (s, 
2H, Hb + Hc), 5.61 (pt, J = 8.0 Hz, 1H, Ha), 5.15, 4.88 (m, 2H, C
1
H2), 
3.75 (s, 3H, OMe
4
), 3.68 (s, 6H, OMe
3
 + OMe
5
). HPLC: Chiralpak AD-
27 
 
H (95/5, n-hexane/2-propanol, 0.5 mL/min); tR, min: 18.4 (major), 20.5 (minor). 
4.3. Preparation of the complexes (SM,RC)-[(Cp*M{(R)-prophos}(9m)](SbF6)2 
[M = Rh (11), Ir (12)] 
At -25ºC, under argon, to a solution of 0.12 mmol of the corresponding complex 
(SM,RC)-[Cp*M(R-prophos)(H2O)](SbF6)2 [M = Rh (1) 136.8 mg, Ir (2) 149.6 mg] in 
CH2Cl2 (20 mL), 75.3 mg (0.36 mmol) of 9m and 100 mg of 4Å MS were added. The 
resulting red suspension was stirred for 1 hour and then filtered through a cannula. The 
filtrate was vaccum-concentrated to about 3mL. The addition 20 mL of n-hexane 
afforded an orange-red solid that was filtered off, washed with n-hexane (5  20 mL) 
and vacuum-dried. Yield: 81.3 % (11), 78.8 % (12). 
4.3.1. (SRh,RC)-[Cp*Rh{(R)-prophos}(9m)](SbF6)2 (11) 
1
H NMR (400.16 MHz, CD2Cl2, -25ºC) δ, ppm: 
7.85-6.95 (23H, Ph), 7.47 (d, J = 13.9 Hz, 1H, 
Ha), 7.31 (d, J = 13.9 Hz, 1H, Hb), 3.89 (s, 3H, 
OMeb), 3.87 (s, 3H, OMea), 3.59 (dm, J(P,H) = 
52.7 Hz, 1H, H21), 3.19 (m, 1H, H11), 2.70 (t, J = 
16.1 Hz 1H, H22), 1.44 (pt, J = 3.3 Hz, 15H, C5Me5), 1.31 (dd, J(P,H) = 13.5, 7.0 Hz, 
3H, Me). 
13
C NMR (100.61 MHz, CD2Cl2, -25ºC) δ, ppm: 152.85-118.98 (Ph), 142.56 
(C
4
), 134.98 (C
3
), 107.29 (bs, C5Me5), 61.67 (OMeb), 56.00 (OMea), 33.5 (dd, J(P,C) = 
35.1, 13.9 Hz, C
2
), 31.22 (dd, J(P,C) = 31.5, 9.5 Hz, C
1
), 15.86 (dd, J(P,C) = 17.6, 5.1 
Hz, Me), 10.08 (C5Me5). 
31
P NMR (161.96 MHz, CD2Cl2, -25ºC) δ, ppm: 75.99 (dd, 
J(Rh,P
1
) = 130.8 Hz, J(P
2
,P
1
) = 38.3 Hz, P
1
), 51.52 ppm (dd, J(Rh,P
2
) = 133.1 Hz, P
2
). 
IR (KBr, cm
-1
): (SbF6): 658 s. Elemental analysis: calcd (%) for 
C47H53F12RhO4NP2Sb2: C 42.4, H 4.0; found: C 42.3, H 4.0. 
4.3.2. (SIr,RC)-[Cp*Ir{(R)-prophos}(9m)](SbF6)2 (12) 
1
H-RMN (400.16 MHz, CD2Cl2, -25ºC) δ, ppm: 
7.60 (bd, 1H, Ha), 7.59-7.26 (m, 23H, Ph), 7.35 
(bd, 1H, Hb), 3.91 (s, 6H, OMea + OMeb), 3.57 
(dm, J(P,H) = 48.1 Hz, 1H, H21), 3.14 (m, 1H, 
H11), 2.64 (m, 1H, H22), 1.53 (bs, 15H, C5Me5), 
1.35 (dd, J(P,H) = 16.1, 9.5 Hz, 3H, Me). 
13
C NMR (100.61 MHz, CD2Cl2, -25ºC) δ, 
28 
 
ppm: 143.93 (C
3
), 134.28-119.83 (Ph, C
4
), 101.40 (C5Me5), 61.69, 56.00 (OMea, 
OMeb), 33.90, 31.67 (m, C
1
, C
2
), 14.76 (dd, J(P,C) = 16.3, 3.8 Hz, 3H, Me), 9.67 ppm 
(C5Me5). 
31
P-RMN (161.96 MHz, CD2Cl2, -25ºC) δ, ppm: 49.04 (d, J(P
2
,P
1
) = 10.7 Hz, 
P
1
), 27.71 ppm (d, P
2
). IR (KBr, cm
-1
): (SbF6): 658 s. Elemental analysis: calcd (%) for 
C47H53F12IrO4NP2Sb2: C 39.7, H 3.7; found: C 39.6, H 3.7. 
4.4. NMR measurements for the 11/4c system 
At -25ºC, under argon, to a solution of 36.4 mg (0.03 mmol) of (SRh,RC)-
[Cp*Rh{(R)-prophos}(H2O)](SbF6)2 (1), in CD2Cl2 (1.0 mL), 12.6 mg (0.06 mmol) of 
9m and 20 mg of 4Å MS were added. The suspension was stirred for 1 hour and placed 
into a 5-mm NMR tube. At -50ºC, 
1
H and 
31
P NMR spectra showed the complete 
formation of complex 11. Then, 5.0 mg (0.03 mmol) of 1,3,5-trimethoxybenzene were 
added and the system was monitored by 
1
H and 
31
P NMR spectroscopies from -50 to  
-10ºC. 
4.5. NMR measurements for the 1/10m system 
In a 5-mm NMR tube, 36.4 mg (0.03 mmol) of (SRh,RC)-[Cp*Rh{(R)-
prophos}(H2O)](SbF6)2 (1) were dissolved in CD2Cl2 (0.5 mL). At -50ºC, 11.3 mg (0.03 
mmol) of 10m and 20 mg of 4Å MS were added. The reaction was monitored by 
1
H and 
31
P NMR spectroscopies. 
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